🔈 🔉 🔊 Last chance to register for the nuclear medicine event on Friday the 28th of June:
Join us as we will share the most recent developments in the field of Nuclear Medicine. Learn about the key findings and recommendations in the report by Chiel Scholten from Technopolis Group. Get a sneak peek of roadmap for nuclear medicine with Wim Oyen, Special Envoy Medical Isotopes of Ministry of Health, Welfare, and Sports.
Hear the ambitions from two key initiatives for the Dutch nuclear medicine ecosystem. Register now: https://lnkd.in/eh7d7N2v
Program
13:00 – 13:30 Reception
Plenary session: Setting the stage
13:30 – 13:35 Welcome – Mark Wijsman (host)
13:35 – 13:50 Fire side chat- How nuclear medicine impact lives – Patient perspective, physician perspective and therapy development perspective
13:50 – 14:10 Overview of the Dutch ecosystem of Nuclear Medicine – Chiel Scholten (Principal consultant Technopolis Group)
14:10 – 14:30 Accelerating radiopharmaceutical development in The Netherlands: a unique infrastructure for collaboration – Wim Oyen (Special Envoy Medical Isotopes of Ministry of Health, Welfare, and Sports, professor Humanitas University, physician Rijnstate hospital)
14:30 – 14:45 Advancing Nuclear Medicine: The DECISIVE Initiative’s Plan to Establish the Netherlands as a Global Leader in Diagnostics and Therapeutics – Bart Cornelissen (Initiator DECISIVE, associate professor UMCG)
14:45 – 15:00 Imaging in drug development, the FORESIGHT initiative – Guus van Dongen (Initiator FORESIGTH, professor Amsterdam UMC, CSO LinXis Pharmaceuticals)
15:00 – 15:15 Break
15:15 – 15:45 Matchmaking sessions
15:45 – 16:00 Break
16:00 – 16:45 Break-out sessions
Theme 1: Nuclear Medicine – What’s in it for you?
Theme 2: Human capital – How to keep up with demand of specialized personnel?
Theme 3: Improve innovation and valorization – What should a center for innovation and valorization do?
Theme 4: Implementation in the clinic – all you need to know about registration, reimbursement and access
16:45 – 17:00 Plenary closing
17:00 – 18:00 Networking
This event aims to bring together all Dutch stakeholders interested in nuclear medicine, from users as health care providers and managers and biotech and pharma professionals to scientists (in (radio) pharmacy, medicine, etc), supply chain partners, technology providers, and government bodies and agencies.
Marlous Kooijman, Wim Oyen, Astrid Freytag, Sandra Heskamp, Bart Cornelissen, Chiel Scholten
#nuclearmedicine #innovation #therapydevelopment